» Articles » PMID: 24909356

MicroRNAs As Oncogenes or Tumour Suppressors in Oesophageal Cancer: Potential Biomarkers and Therapeutic Targets

Overview
Journal Cell Prolif
Date 2014 Jun 10
PMID 24909356
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs are a class of small, non-coding RNAs that can negatively regulate protein-coding genes, and are associated with almost all known physiological and pathological processes, especially cancer. The number of studies documenting miRNA expression patterns in malignancy continues to expand rapidly, with continuously gained critical information regarding how aberrantly expressed miRNAs may contribute to carcinogenesis. miRNAs can influence cancer pathogenesis, playing a potential role as either oncogenes or tumour suppressors. Recently, several miRNAs have been reported to exert different regulatory functions in oesophageal cancer - the carcinoma typically arising from the epithelial lining of the oesophagus. These miRNAs also have potential clinical applications towards developing biomarkers or targets for possible use in diagnosis or therapy in oesophageal cancer. In this review, we have summarized the two (oncogenic or tumour suppressive) roles of miRNAs here, and their applications as potential biomarkers or therapeutic targets, which may illuminate future treatment for oesophageal cancer.

Citing Articles

PAQR4 oncogene: a novel target for cancer therapy.

Patil D, Raut S, Joshi M, Bhatt P, Bhatt L Med Oncol. 2024; 41(6):161.

PMID: 38767705 DOI: 10.1007/s12032-024-02382-w.


The Role of Autophagy in Human Uveal Melanoma and the Development of Potential Disease Biomarkers and Novel Therapeutic Paradigms.

Wang J, Paulus P, Niu Y, Zhu L, Morisseau C, Rawling T Biomedicines. 2024; 12(2.

PMID: 38398064 PMC: 10886749. DOI: 10.3390/biomedicines12020462.


Molecular Biology and Clinical Management of Esophageal Adenocarcinoma.

Li S, Hoefnagel S, Krishnadath K Cancers (Basel). 2023; 15(22).

PMID: 38001670 PMC: 10670638. DOI: 10.3390/cancers15225410.


LncRNA SEMA3B-AS1 inhibits breast cancer progression by targeting miR-3940/KLLN axis.

Hu J, Huang H, Xi Z, Ma S, Ming J, Dong F Cell Death Dis. 2022; 13(9):800.

PMID: 36123344 PMC: 9485163. DOI: 10.1038/s41419-022-05189-7.


Targeting Autophagy for Developing New Therapeutic Strategy in Intervertebral Disc Degeneration.

Bahar M, Hwang J, Ahmed M, Lai T, Pham T, Elashkar O Antioxidants (Basel). 2022; 11(8).

PMID: 36009290 PMC: 9405341. DOI: 10.3390/antiox11081571.


References
1.
Sun J, Chen Z, Tan X, Zhou F, Tan F, Gao Y . MicroRNA-99a/100 promotes apoptosis by targeting mTOR in human esophageal squamous cell carcinoma. Med Oncol. 2013; 30(1):411. DOI: 10.1007/s12032-012-0411-9. View

2.
Zhang H, Zhang K, Liao L, Li L, Du Z, Wu B . miR-200b suppresses invasiveness and modulates the cytoskeletal and adhesive machinery in esophageal squamous cell carcinoma cells via targeting Kindlin-2. Carcinogenesis. 2013; 35(2):292-301. DOI: 10.1093/carcin/bgt320. View

3.
Gu J, Wang Y, Wu X . MicroRNA in the pathogenesis and prognosis of esophageal cancer. Curr Pharm Des. 2012; 19(7):1292-300. DOI: 10.2174/138161213804805775. View

4.
Trivers K, Sabatino S, Stewart S . Trends in esophageal cancer incidence by histology, United States, 1998-2003. Int J Cancer. 2008; 123(6):1422-8. DOI: 10.1002/ijc.23691. View

5.
Bansal A, Lee I, Hong X, Anand V, Mathur S, Gaddam S . Feasibility of mcroRNAs as biomarkers for Barrett's Esophagus progression: a pilot cross-sectional, phase 2 biomarker study. Am J Gastroenterol. 2011; 106(6):1055-63. DOI: 10.1038/ajg.2011.37. View